{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T05:54:49Z","timestamp":1777614889281,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T00:00:00Z","timestamp":1726531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Medicine"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.sleep.2024.09.024","type":"journal-article","created":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T21:47:35Z","timestamp":1726609655000},"page":"209-216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Efficacy of once-nightly sodium oxybate (FT218) on daytime symptoms in individuals with narcolepsy with or without concomitant alerting agent use: A post hoc analysis from the phase 3 REST-ON trial"],"prefix":"10.1016","volume":"124","author":[{"given":"Yves","family":"Dauvilliers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Roth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Bogan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Thorpy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne Marie","family":"Morse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asim","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Gudeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.sleep.2024.09.024_bib1","article-title":"Narcolepsy","volume":"3","author":"Kornum","year":"2017","journal-title":"Nat Rev Dis Prim"},{"issue":"9560","key":"10.1016\/j.sleep.2024.09.024_bib2","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0140-6736(07)60237-2","article-title":"Narcolepsy with cataplexy","volume":"369","author":"Dauvilliers","year":"2007","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.sleep.2024.09.024_bib3","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1111\/ene.14888","article-title":"European guideline and expert statements on the management of narcolepsy in adults and children","volume":"28","author":"Bassetti","year":"2021","journal-title":"Eur J Neurol"},{"issue":"Supplement_1","key":"10.1016\/j.sleep.2024.09.024_bib4","doi-asserted-by":"crossref","first-page":"A262","DOI":"10.1093\/sleep\/zsad077.0597","article-title":"0597 path to diagnosis and impact of narcolepsy on quality of life: a survey of people living with narcolepsy","volume":"46","author":"Ortiz","year":"2023","journal-title":"Sleep"},{"issue":"9","key":"10.1016\/j.sleep.2024.09.024_bib5","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.5664\/jcsm.9328","article-title":"Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine clinical practice guideline","volume":"17","author":"Maski","year":"2021","journal-title":"J Clin Sleep Med"},{"issue":"4","key":"10.1016\/j.sleep.2024.09.024_bib6","first-page":"306","article-title":"Treatment of narcolepsy with methamphetamine","volume":"16","author":"Mitler","year":"1993","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2024.09.024_bib7","series-title":"The voice of the patient: narcolepsy","year":"2014"},{"issue":"1","key":"10.1016\/j.sleep.2024.09.024_bib8","first-page":"42","article-title":"A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy","volume":"25","year":"2002","journal-title":"Sleep"},{"issue":"1","key":"10.1016\/j.sleep.2024.09.024_bib9","first-page":"31","article-title":"A 12-month, open-label, multicenter extension trial of orally administered sodium oxybate for the treatment of narcolepsy","volume":"26","year":"2003","journal-title":"Sleep"},{"issue":"2","key":"10.1016\/j.sleep.2024.09.024_bib10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.sleep.2003.11.002","article-title":"Sodium oxybate demonstrates long-term efficacy for the treatment of cataplexy in patients with narcolepsy","volume":"5","year":"2004","journal-title":"Sleep Med"},{"issue":"7","key":"10.1016\/j.sleep.2024.09.024_bib11","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1093\/sleep\/29.7.939","article-title":"Sodium oxybate improves excessive daytime sleepiness in narcolepsy","volume":"29","author":"Black","year":"2006","journal-title":"Sleep"},{"issue":"8","key":"10.1016\/j.sleep.2024.09.024_bib12","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.sleep.2009.05.004","article-title":"The nightly administration of sodium oxybate results in significant reduction in the nocturnal sleep disruption of patients with narcolepsy","volume":"10","author":"Black","year":"2009","journal-title":"Sleep Med"},{"issue":"6","key":"10.1016\/j.sleep.2024.09.024_bib13","doi-asserted-by":"crossref","first-page":"596","DOI":"10.5664\/jcsm.27994","article-title":"The nightly use of sodium oxybate is associated with a reduction in nocturnal sleep disruption: a double-blind, placebo-controlled study in patients with narcolepsy","volume":"6","author":"Black","year":"2010","journal-title":"J Clin Sleep Med"},{"issue":"4","key":"10.1016\/j.sleep.2024.09.024_bib14","doi-asserted-by":"crossref","first-page":"427","DOI":"10.5664\/jcsm.4598","article-title":"Time to response with sodium oxybate for the treatment of excessive daytime sleepiness and cataplexy in patients with narcolepsy","volume":"11","author":"Bogan","year":"2015","journal-title":"J Clin Sleep Med"},{"issue":"3","key":"10.1016\/j.sleep.2024.09.024_bib15","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsaa206","article-title":"Efficacy and safety of calcium, magnesium, potassium, and sodium oxybates (lower-sodium oxybate [LXB]; JZP-258) in a placebo-controlled, double-blind, randomized withdrawal study in adults with narcolepsy with cataplexy","volume":"44","author":"Bogan","year":"2021","journal-title":"Sleep"},{"issue":"6","key":"10.1016\/j.sleep.2024.09.024_bib16","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsab200","article-title":"Once-nightly sodium oxybate (FT218) demonstrated improvement of symptoms in a phase 3 randomized clinical trial in patients with narcolepsy","volume":"45","author":"Kushida","year":"2022","journal-title":"Sleep"},{"issue":"4","key":"10.1016\/j.sleep.2024.09.024_bib17","doi-asserted-by":"crossref","first-page":"391","DOI":"10.5664\/jcsm.26368","article-title":"A double-blind, placebo-controlled study demonstrates sodium oxybate is effective for the treatment of excessive daytime sleepiness in narcolepsy","volume":"1","year":"2005","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.sleep.2024.09.024_bib18","article-title":"LUMRYZ\u2122 (sodium oxybate for extended-release oral suspension, CIII). Full Prescribing Information. Chesterfield, MO","year":"2023","journal-title":"Avadel Pharmaceuticals"},{"issue":"4","key":"10.1016\/j.sleep.2024.09.024_bib19","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s40263-022-00904-6","article-title":"Effect of FT218, a once-nightly sodium oxybate formulation, on disrupted nighttime sleep in patients with narcolepsy: results from the randomized phase III REST-ON trial","volume":"36","author":"Roth","year":"2022","journal-title":"CNS Drugs"},{"key":"10.1016\/j.sleep.2024.09.024_bib20","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsad152","article-title":"Efficacy of once-nightly sodium oxybate (FT218) in narcolepsy type 1 and type 2: post hoc analysis from the phase 3 REST-ON trial","author":"Dauvilliers","year":"2023","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2024.09.024_bib21","series-title":"International classification of sleep disorders. Darien","year":"2014"},{"issue":"6","key":"10.1016\/j.sleep.2024.09.024_bib22","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","article-title":"A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale","volume":"14","author":"Johns","year":"1991","journal-title":"Sleep"},{"issue":"5","key":"10.1016\/j.sleep.2024.09.024_bib23","doi-asserted-by":"crossref","first-page":"665","DOI":"10.5664\/jcsm.6576","article-title":"AASM scoring manual updates for 2017 (version 2.4)","volume":"13","author":"Berry","year":"2017","journal-title":"J Clin Sleep Med"},{"issue":"9","key":"10.1016\/j.sleep.2024.09.024_bib24","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.5664\/jcsm.9326","article-title":"Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment","volume":"17","author":"Maski","year":"2021","journal-title":"J Clin Sleep Med"},{"issue":"3","key":"10.1016\/j.sleep.2024.09.024_bib29","doi-asserted-by":"crossref","first-page":"419","DOI":"10.5664\/jcsm.6494","article-title":"Listening to the patient voice in narcolepsy: diagnostic delay, disease burden, and treatment efficacy","volume":"13","author":"Maski","year":"2017","journal-title":"J Clin Sleep Med"},{"issue":"5","key":"10.1016\/j.sleep.2024.09.024_bib30","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.sleep.2005.03.010","article-title":"Further evidence supporting the use of sodium oxybate for the treatment of cataplexy: a double-blind, placebo-controlled study in 228 patients","volume":"6","year":"2005","journal-title":"Sleep Med"},{"issue":"9","key":"10.1016\/j.sleep.2024.09.024_bib31","doi-asserted-by":"crossref","first-page":"955","DOI":"10.5664\/jcsm.3004","article-title":"Disrupted nighttime sleep in narcolepsy","volume":"9","author":"Roth","year":"2013","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.sleep.2024.09.024_bib32","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.sleep.2017.07.030","article-title":"Effect of sodium oxybate, modafinil, and their combination on disrupted nighttime sleep in narcolepsy","volume":"40","author":"Dauvilliers","year":"2017","journal-title":"Sleep Med"},{"issue":"4","key":"10.1016\/j.sleep.2024.09.024_bib33","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/jsr.12468","article-title":"Effect of sodium oxybate on disrupted nighttime sleep in patients with narcolepsy","volume":"26","author":"Roth","year":"2017","journal-title":"J Sleep Res"},{"issue":"6","key":"10.1016\/j.sleep.2024.09.024_bib34","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsac054","article-title":"Linking clinical complaints and objective measures of disrupted nighttime sleep in narcolepsy type 1","volume":"45","author":"Barateau","year":"2022","journal-title":"Sleep"},{"issue":"1","key":"10.1016\/j.sleep.2024.09.024_bib35","doi-asserted-by":"crossref","first-page":"289","DOI":"10.5664\/jcsm.9638","article-title":"Disrupted nighttime sleep and sleep instability in narcolepsy","volume":"18","author":"Maski","year":"2022","journal-title":"J Clin Sleep Med"}],"container-title":["Sleep Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S138994572400443X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S138994572400443X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T04:17:45Z","timestamp":1737778665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S138994572400443X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":31,"alternative-id":["S138994572400443X"],"URL":"https:\/\/doi.org\/10.1016\/j.sleep.2024.09.024","relation":{},"ISSN":["1389-9457"],"issn-type":[{"value":"1389-9457","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of once-nightly sodium oxybate (FT218) on daytime symptoms in individuals with narcolepsy with or without concomitant alerting agent use: A post hoc analysis from the phase 3 REST-ON trial","name":"articletitle","label":"Article Title"},{"value":"Sleep Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sleep.2024.09.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}